top of page
jumbo phages have expanded genomes conferring them unique
biological properties, of high
potential to develop novel
Therapeutics targeting diseases mediated by bacteria
News & PRess
> Sep '23
new Grant from anii
To expand our in vitro data package on the efficacy of jumbo phages to kill superbugs
The National Research and Innovation Agency of Uruguay (ANII) selected Kinzbio for additional non-dilutive
funding that will be used to expand our panel of clinical bacterial strains and test our jumbo phages against them.
The proposal was submitted in collaboration with CLAEH, an emerging private university with strong connections with public and private hospitals in the east region of the country. This important partnership allows Kinzbio to get access to clinical strains and epidemiological data of top-priority pathogens circulating in three main healthcare centers.
The project is focused on generating a vastly diverse biobank of multi-drug resistant bacteria including Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae and Pseudomonas aeruginosa, isolated from different clinical presentations. Together with whole-genome sequencing characterization and phenotyping, these strains will be used as a panel to test Kinzbio's jumbo bacteriophages.
This aims to reinforce our evidence that jumbo phages are able to kill a broad range of genetically diverse and multi-drug resistant strains, guiding next steps to their application as antimicrobials.
unleashing the potential of
Jumbo phages
together
Kinzbio fosters collaborations and partnerships with pharma leaders, clinical organizations, academic labs and funding agencies to help the company to accelerate the development of its jumbo phage platform and pipeline.
Kinzbio has an open communication channel with and is always seeking to hear from industry partners and funding institutions interested in joining efforts to keep developing applications based on the biology of jumbo phages.
BE IN
TOUCH
Please fill your contact details below:
Phage technologies for a
healthier world
MODERN LIFESTYLE
Is weakening the
human microbiome
giving room to
pathogens that spread
antimicrobial resistance
and promote inflammation
phages are natural
bacterial killers
that can be used to
combat these pathogens
News
Partnering
Contact
bottom of page